perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation
Clicks: 196
ID: 184670
2013
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Steady Performance
30.0
/100
195 views
20 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Reconstructive transplantation has emerged as clinical reality over the past decade. Utilizing standard immunosuppressive drugs has proven feasible in face and hand transplantation to achieve long-term graft acceptance. As vascularized composite tissue allotransplantation is not a life-saving procedure compared to solid organ transplantation alternative protocols with less long-term side effects are even more desirable. Allograft tolerance is the holy grail of many cell-based concepts and recent data in the field is most promising. Immunomodulation with mesenchymal stem cells from bone marrow and adipose tissue has shown high potential in this respect. This article is aiming at giving an overview on the experimental studies available, the scientific background and clinical applications. Furthermore we address essential questions prior to the use of mesenchymal stem cells in reconstructive allotransplantation.
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (126 words).
Try re-searching for a better abstract.
| Reference Key |
plock2013frontiersperspectives
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Jan A. Plock;Jan A. Plock;Jonas T. Schnider;Mario G. Solari;Xin Xiao eZheng;Xin Xiao eZheng;Vijay S. Gorantla |
| Journal | sudebno-meditsinskaia ekspertiza |
| Year | 2013 |
| DOI |
10.3389/fimmu.2013.00175
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.